513 related articles for article (PubMed ID: 33257492)
1. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study.
Liu QQ; Cheng A; Wang Y; Li H; Hu L; Zhao X; Wang T; He F
BMJ Open; 2020 Nov; 10(11):e041471. PubMed ID: 33257492
[TBL] [Abstract][Full Text] [Related]
2. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
[TBL] [Abstract][Full Text] [Related]
4. Analysis of inflammatory parameters and disease severity for 88 hospitalized COVID-19 patients in Wuhan, China.
Xu X; Yu MQ; Shen Q; Wang LZ; Yan RD; Zhang MY; Liu JY; Qu YQ
Int J Med Sci; 2020; 17(13):2052-2062. PubMed ID: 32788884
[No Abstract] [Full Text] [Related]
5. Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study.
Cui N; Yan R; Qin C; Zhao J
Front Cell Infect Microbiol; 2020; 10():595333. PubMed ID: 33365277
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia.
Jia F; Wang G; Xu J; Long J; Deng F; Jiang W
Aging (Albany NY); 2021 Nov; 13(21):23895-23912. PubMed ID: 34725309
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and clinical features of deterioration in COVID-19 patients in Zhejiang, China: a single-centre, retrospective study.
Yi P; Yang X; Ding C; Chen Y; Xu K; Ni Q; Zhao H; Li Y; Zhang X; Liu J; Sheng J; Li L
BMC Infect Dis; 2020 Dec; 20(1):943. PubMed ID: 33302889
[TBL] [Abstract][Full Text] [Related]
9. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.
Quartuccio L; Fabris M; Sonaglia A; Peghin M; Domenis R; Cifù A; Curcio F; Tascini C
Cytokine; 2021 Apr; 140():155438. PubMed ID: 33493861
[TBL] [Abstract][Full Text] [Related]
11. [Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan].
Zhang J; Gao XL; Li DJ; Jiang Y; Liu Y; Pang L; Xu D; Yang LH
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):927-931. PubMed ID: 33333696
[No Abstract] [Full Text] [Related]
12. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
14. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
Chen L; Liu HG; Liu W; Liu J; Liu K; Shang J; Deng Y; Wei S
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):203-208. PubMed ID: 32164089
[No Abstract] [Full Text] [Related]
16. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
Ni M; Tian FB; Xiang DD; Yu B
J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of IL-8 for the death of severe or critical patients with COVID-19.
Li H; Zhang J; Fang C; Zhao X; Qian B; Sun Y; Zhou Y; Hu J; Huang Y; Ma Q; Hui J
Medicine (Baltimore); 2021 Mar; 100(11):e23656. PubMed ID: 33725924
[TBL] [Abstract][Full Text] [Related]
18. Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity.
Tang Y; Sun J; Pan H; Yao F; Yuan Y; Zeng M; Ye G; Yang G; Zheng B; Fan J; Pan Y; Zhao Z; Guo S; Liu Y; Liao F; Duan Y; Jiao X; Li Y
Cytokine; 2021 Jul; 143():155523. PubMed ID: 33840589
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
Xu Y; Qian Y; Gu Q; Tang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
